1146P - Metformin Impact on Progression-Free Survival in Advanced Pancreatic Well-Differentiated Neuroendocrine Tumors (Pwdnets). Retrospective Evaluation in Diabetic Patients Receiving Everolimus Plus Octreotide Lar Treatment

Autor: Pusceddu, S., De Braud, F.G.M., Concas, L., Bregant, C., Festinese, F., Giacomelli, L., D'Autilia, E., Formisano, B., Mazzaferro, V., Buzzoni, R.
Zdroj: In Annals of Oncology September 2014 25 Supplement 4:iv400-iv400
Databáze: ScienceDirect